Company: RVRC
Filing Date: 2025-12-12
Form Type: S-1/A
Source: 0001213900-25-121070
Chunk: 167

Company: Revium Rx.
Filing Date: 2025-12-12
Form: S-1/A
Chunk 167
---
 2008, he was associated with the Israel office of Deloitte, where he led
and participated in numerous financial audits for organization of various sizes.

Mr. Avraham is a licensed CPA and holds an MBA
in Finance from the Hebrew University of Jerusalem.

Inna Martin, 49, has joined the Company
as Chief Executive Officer, President and director in November 2019 and served as Chief Executive Officer through December 22, 2024,
whereupon she resigned from such position, but continues to serve as a director and President of the Company. Since December 17, 2024,
she is serving as Chief Operating Officer. Ms. Martin has an extensive experience of more than 20 years in healthcare and project management.Between December 2022 and February 2024, she served on the board of directors of
IR Med, Inc. (OTCQB: IRME), a clinical stage medical device company focused on the development of infrared spectroscopy and AI analysis
technology platform as a basis for point-of-care decision support devices. From February 2014 until April 2018, Inna Martin served as
Investment Director at a Luxembourg based, a healthcare focused VC fund, partner of Domain Associates LLC (USA), where she managed portfolio
companies in major innovation hubs including North America and Europe. In September 2018, she founded Seven Sons Ltd., Israel, a clinical
stage medical device company, focusing on the development of Stent Positioning Assistance System, SPAS, a novel proprietary tool developed
for safer PCI procedure and precise stent positioning.

Inna Martin received her MBA in 2000 fromBar Ilan University, Israel, her BA in English and Psychology in 1996 from Orenburg State University, Russian
Federation. In 2021, she received certification in Management Executive Education, Artificial Intelligence in Health Care from MIT, MA.

Arie Gordashnikov, 42, became the Company’s
Chief Financial Officer. effective as of June I, 2023. He has over 13 years of experience in accounting, auditing and finance of Hi-Tech
and biotechnology companies. Since 2018, he serves as Head of IPO & M&A Department at Shimony Financial Services (Israel) and
has been providing accounting and financial advisory services to the Company since 2018. He knows company’s history, prepared all
quarterly and annual reports, experienced in RCC and PCAOB reporting. Before joining Shimony CPA FIRM, from